April 2026 ZOHU Call

What to know

  • A video recording of this webinar is posted below. Visit CDC TRAIN to get free continuing education (CE) for this webinar.
  • The TRAIN course registration code is ZOHUwebcast

1 hour

Apr 1, 2026

Webinar details

Presentation topics

  • Human Cases of Carbapenemase-Producing Escherichia coli Linked to Spread Between Animals and the Environment in a Veterinary Facility—Massachusetts, USA, 2023
  • Francisella tularensis Subspecies holarctica in Stranded Beluga Whales, Cook Inlet, Alaska, USA

Featuring

Stephen Cole, VMD, MS, DACVM | Presenter
Assistant Professor of Microbiology
University of Pennsylvania
Ian DeStefano DVM, DACVECC | Presenter
Assistant Clinical Professor, Emergency and Critical Care
Cummings School of Veterinary Medicine, Tufts University
Natalie Rouse | Presenter
Necropsy Biologist
Alaska Veterinary Pathology Services, University of Alaska

Continuing Education (CE)

Visit CDC Train to receive free CE.

Webcast (Live)

  • Course Name: WC4565R-040126
  • Registration Code: ZOHUwebcast
  • Start Date: April 1, 2026
  • End Date: May 4, 2026

Web-on-Demand (Recording)

  • Course Name: WD4565R-040126
  • Start Date: May 5, 2026
  • End Date: May 5, 2028

Series objectives

1. Identify an implication for human, animal, and environmental health.

2. Identify a One Health approach strategy for prevention of public health threats.

3. Identify a One Health approach strategy for detection of public health threats.

4. Identify a One Health approach strategy for responding to public health threats.

5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial or in-kind support for this activity.